Since SNRNP70 is a key early regulator of 5′ splice site selection, it is possible that SNRNP70 acts as an effector of alternative splicing of SETMAR mRNA and may serve as a major, albeit not yet fully understood, marker of GBM [45]. This evidence concerns the gene SETMAR and glioblastoma.